Orthokeratology Lens Market Set to Reach US$950 Mn by 2031 Driven by Rising Myopia Cases and Growing Pediatric Adoption


The global orthokeratology lens market is witnessing robust expansion on the back of rising refractive errors worldwide. Valued at approximately US$712.4 million in 2024, the market is projected to reach nearly US$950 million by 2031, expanding at a compound annual growth rate (CAGR) of 6.9% between 2024 and 2031. Compared to the CAGR of 6.5% observed between 2019 and 2023, the industry shows an accelerating trajectory, underscoring its growing significance in global eye care.

Orthokeratology lenses, commonly known as Ortho-K or OK lenses, have emerged as a preferred non-surgical vision correction solution. They are increasingly being adopted by patients looking to manage myopia progression and avoid the complications of refractive surgery. Rising awareness, technological advancements, and an alarming surge in pediatric myopia cases are all fueling the growth of this market.

Rising Burden of Refractive Errors Driving Adoption

The exponential rise in refractive errors, particularly myopia, is the strongest driver of the orthokeratology lens industry. Research from Investigative Ophthalmology and Visual Science highlights that nearly 28% of the world’s population currently suffers from myopia, a number expected to escalate sharply in the coming years. The World Health Organization forecasts that global myopia prevalence will reach 52% by 2050, equating to more than 4.8 billion individuals.

Increased screen exposure, especially among children during the COVID-19 pandemic, has exacerbated this trend. Orthokeratology lenses have therefore gained traction as a proactive, non-invasive treatment that not only corrects vision temporarily but also slows down myopia progression. For parents, this presents an attractive alternative to glasses and an early intervention before surgical options become viable.

Key Trends Shaping the Market

Rising Demand for Overnight Ortho-K Lenses

Overnight lenses, which account for more than 90% of global market share, are driving demand thanks to their convenience and comfort. Users wear them while sleeping, waking up with corrected vision without the need for glasses or daytime contacts.

Expanding Adoption Across Asian Markets

Asia Pacific, home to the highest prevalence of myopia worldwide, is witnessing growing acceptance of orthokeratology lenses. Rapid urbanization, increasing awareness, and new product launches targeted at children are propelling regional demand.

Technological Advancements and Novel Lens Designs

Leading players are focusing on product innovation, incorporating improved materials and fitting designs to enhance comfort and safety. Menicon’s Z Night lens and CooperVision’s Dreamlite OK lens are prime examples of new-generation lenses.

Pediatric Myopia Management at the Forefront

A growing body of research demonstrates the effectiveness of ortho-K lenses in slowing down axial eye elongation in children. As childhood myopia becomes an epidemic, pediatric-focused ortho-K lenses represent a major growth opportunity.

Market Growth Drivers

Proactive Myopia Management

Unlike corrective glasses that address symptoms, orthokeratology offers preventative care. This is especially appealing in pediatric cases, where early intervention can prevent severe long-term visual impairment.

Research and Development Surge

Major market players are investing heavily in R&D to develop lenses optimized for comfort, durability, and effectiveness. Strategic collaborations are further accelerating innovation. Johnson & Johnson Vision’s ACUVUE Abiliti launch in Singapore highlights this trend.

Demand for Non-Surgical Alternatives

Concerns over surgical risks such as dry eye, halos, and glare are pushing patients toward ortho-K lenses. They offer a reversible, child-friendly, and surgery-free approach to vision correction.

Market Restraints

Despite strong growth, several barriers remain. The high cost of ortho-K treatment, encompassing fitting, ongoing lens replacement, and maintenance, limits adoption in cost-sensitive markets. Insurance coverage is sparse in many regions, particularly in developing economies, creating affordability challenges for families.

Additionally, patient awareness outside urban areas remains low, posing a challenge to widespread adoption.

Historical Growth and Pandemic Impact

The orthokeratology lens market experienced a temporary downturn during the COVID-19 pandemic, as lockdowns disrupted ophthalmic services and delayed non-urgent treatments. However, the surge in myopia cases linked to prolonged screen exposure ironically boosted post-pandemic demand. Since 2021, the market has rebounded strongly, with renewed focus on pediatric vision care.

Future Opportunities

The most promising opportunity lies in addressing the pediatric myopia epidemic, especially in Asia. Lens designs tailored to children—featuring improved comfort and ease of use—will unlock a large untapped market. With rising parental awareness and demand for proactive vision management, manufacturers are well-positioned to expand their footprint in this space.

Category-Wise Insights

By Lens Type: Overnight Ortho-K Dominates

Overnight ortho-K lenses account for over 90% of total revenues, a dominance likely to persist through 2031. Their effectiveness, convenience, and increasing regulatory approvals solidify their leadership position. Daytime ortho-K lenses remain niche due to discomfort and dryness issues.

By Indication: Myopia Leads with 41% Share

Myopia remains the primary indication, contributing 41% of global demand. Rising prevalence among children is the key driver. Astigmatism also represents a sizable opportunity, with nearly one-third of Americans affected. Orthokeratology offers a viable alternative for patients seeking non-surgical options.

By Distribution Channel: Hospitals Hold the Edge

Hospitals currently dominate distribution with a 25% market share, benefiting from advanced facilities and trained professionals. However, ophthalmic clinics are gaining traction, particularly in developing regions, where they offer cost-effective and accessible alternatives.

Regional Analysis

North America: Innovation Hub

North America leads the global orthokeratology lens market, accounting for 38% of revenues in 2024. Strong presence of global players such as Johnson & Johnson Vision, CooperVision, and Bausch & Lomb, coupled with continuous product innovation, underpins regional dominance. Strategic partnerships, like the Johnson & Johnson–Menicon collaboration, reinforce the region’s leadership in pediatric myopia management.

Asia Pacific: Fastest-Growing Market

Asia Pacific is projected to experience exponential growth through 2031. The region’s high myopia prevalence, expanding healthcare infrastructure, and rising awareness make it a focal point for global players. Recent investments, such as Menicon’s subsidiary in China, highlight the region’s strategic importance. Markets like China and India, with large pediatric populations and increasing disposable incomes, represent unparalleled opportunities for growth.

Europe, Latin America, and MEA

Europe continues to adopt advanced ortho-K solutions, driven by regulatory approvals such as CE certification for CooperVision’s Dreamlite lenses. Latin America and the Middle East & Africa are at earlier stages of adoption but show promise due to growing healthcare investments and increasing ophthalmic clinic presence.

Competitive Landscape

The orthokeratology lens market is moderately consolidated, with key players focusing on product innovation, regulatory approvals, and strategic partnerships to strengthen market presence.

Leading Companies

  • Bausch & Lomb Inc.

  • Johnson & Johnson Vision Care, Inc.

  • CooperVision

  • Euclid Systems Corp.

  • GP Specialists

  • Alpha Corporation (Menicon Group)

  • MiracLens L.L.C.

  • Brighten Optix Co.

  • Art Optical Contact Lens, Inc.

  • TruForm Optics, Inc.

Notable Industry Developments

  • September 2023: AccuLens launched its FDA-approved NewVision SC, a corneoscleral Ortho-K lens designed for enhanced comfort.

  • September 2021: Scotlens partnered with Avizor to introduce an innovative ortho-K lens packaging experience.

  • May 2021: Johnson & Johnson Vision received FDA approval for its first ortho-K lens specifically targeting pediatric myopia.

  • May 2021: CooperVision’s Procornea Dreamlite lens received CE approval in Europe, designed to slow myopia progression in children.

Market Segmentation Overview

By Indication

  • Myopia

  • Hypermetropia

  • Presbyopia

  • Astigmatism

By Product Type

  • Overnight Ortho-K Lens

  • Daytime Ortho-K Lens

By Distribution Channel

  • Ophthalmology Clinics

  • Optometry Clinics

  • Hospitals

  • Others

By Region

  • North America

  • Europe

  • Latin America

  • Western & Eastern Europe

  • South Asia & Pacific

  • East Asia

  • Middle East & Africa

Conclusion

The orthokeratology lens market is poised for steady growth, fueled by rising global myopia prevalence, increasing adoption of non-surgical treatments, and strong pediatric demand. While challenges such as affordability and limited insurance coverage remain, ongoing innovation, regulatory approvals, and geographic expansion are expected to mitigate these barriers.

By 2031, the market’s valuation of US$950 million will not only reflect strong demand for vision correction but also underscore the critical role of orthokeratology lenses in global eye health management.

Read Related Reports:

Rna Analysis Market

Defibrillator Market

Laboratory Informatics Market

Infectious Disease In Vitro Diagnostics Market

Comments

Post a Comment

Popular posts from this blog

Legionella Testing Market Expansion Supported by Rising Awareness of Legionnaires’ Disease

Image
  The global legionella testing market , which is currently valued at USD 322.4 million in 2026, is projected to grow substantially, reaching USD 547.8 million by 2033. This robust growth represents a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033. Several factors, including the rising incidence of Legionnaires' disease and increasing government regulations around water safety management, are fueling this expansion. As the prevalence of waterborne diseases like Legionnaires' disease escalates globally, the demand for reliable and efficient testing methods continues to rise, creating significant opportunities within the market. Market Dynamics: Drivers and Challenges Driver: Rising Incidence of Legionnaires' Disease and Aging Infrastructure One of the primary drivers of the legionella testing market’s growth is the increasing number of Legionnaires' disease cases globally. According to the Centers for Disease Control and Prevention (CDC), in the United Sta...
Read more

Antibody Testing Market Expands Amid Rising Demand for Accurate COVID-19 Screening Solutions

 The global antibody testing market is set for substantial expansion over the next decade, driven by growing demand for accurate diagnostic tools, increasing prevalence of infectious and chronic diseases, and significant advancements in immunodiagnostic technologies. According to the latest industry analysis, the global antibody testing market size is expected to be valued at US$9.4 billion in 2025 and projected to reach US$16 billion by 2032 , growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2025 to 2032. Market Overview Antibody testing, also known as serology testing, plays a crucial role in detecting the presence of antibodies in the blood, indicating an immune response to infections, vaccines, or autoimmune disorders. Over the past few years, the market has witnessed accelerated growth due to the increased demand for diagnostic tests following the COVID-19 pandemic. The rise in awareness regarding preventive healthcare, increasing healt...
Read more

UAE Health Check-up Market Set for Robust Growth Driven by Preventive Healthcare Initiatives

Image
  The UAE health check-up market is on a strong growth trajectory, projected to reach US$ 113.8 million by 2032, up from US$ 77.0 million in 2025, reflecting a compound annual growth rate (CAGR) of around 5.0% during the forecast period. This growth reflects a notable transformation in the UAE’s healthcare landscape, where residents are increasingly shifting from reactive treatment approaches to proactive, preventive care. Regular health check-ups are now being recognized as essential components of personal well-being rather than optional services. The growing focus on lifestyle disease management, government-led health campaigns, mandatory screenings for residency and employment, and innovative diagnostic technologies are driving this trend, particularly in urban hubs like Abu Dhabi and Dubai. Key Industry Highlights General health check-ups are expected to hold a dominant share in 2025, driven by the adoption of wellness programs among corporates. Companies are increasingly inco...
Read more